Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (19242)	3/4/1999 10:53:00 PM
From: VLAD	Read Replies (2) \| Respond to of 23519

There is a poster here who believes that negative Viagra news will never have any impact on Vivus. I say that if news that is negative regarding Viagra has no results in the regulation of Viagra then this may be so. But if negative Viagra news ever gets the FDA to do more than one vague relabeling of Viagra then it is a positive for Vivus. I found it quite strange that during the ACC's review on Viagra, they found it necessary to show their findings first to Pfizer for their opinion/input before producing their final draft. Why was that necessary??? It's kind of like farmers allowing foxes to review a report regarding the raiding of chicken coups. The foxes tell the farmers, "you can't report that the chickens died from having their heads bitten off by the foxes, but you must say that having the chicken coup raided by foxes is stressful and leads to heart attacks BEFORE the chickens are ever decapitated." Believe what you want but I still say if we were dealing with any other drug other than a drug that makes old men's peni stiff we certainly wouldn't be seeing such a bias of politics and big pharma money over science!